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Abstract 
 
Background: National or local laws, norms or regulations (sometimes and in some 
countries) require medical providers to report notifiable diseases to public health 
authorities.  Reporting, however, is almost always incomplete. This is due to a variety 
of reasons, ranging from not recognizing the diseased to failures in the technical or 
administrative steps leading to the final official register in the disease notification 
system. The reported fraction varies from 9% to 99% and is strongly associated with the 
disease being reported.  
 
Methods: In this paper we propose a method to approximately estimate the full 
prevalence (and any other variable or parameter related to transmission intensity) of 
infectious diseases. The model assumes incomplete notification of incidence and allows 
the estimation of the non-notified number of infections and it is illustrated by the case of 
hepatitis C in Brazil. The method has the advantage that it can be corrected iteratively 
by comparing its findings with empirical results. 
 
Results: The application of the model for the case of hepatitis C in Brazil resulted in a 
prevalence of notified cases that varied between 163,902 and 169,382 cases; a 
prevalence of non-notified cases that varied between 1,433,638 and 1,446,771; and a 
total prevalence of infections that varied between 1,597,540 and 1,616,153 cases. 
 
Conclusions: We conclude that that the model proposed can be useful for estimation of 
the actual magnitude of endemic states of infectious diseases, particularly for those 
where the number of notified cases is only the tip of the iceberg. In addition, the method 
can be applied to other situations, such as the well-known underreported incidence of 
criminality (for example rape), among others. 
 
 
Keywords: Hepatitis C; Mathematical Models; Notifications System Incidence; 
Prevalence. 
 
3 
 
 
 
Background 
 
Compulsory notifiable diseases (CNDs) are those diseases that should be compulsorily 
reported to Health Authorities as soon as suspected by the attending professional [1]. 
The notified cases then enter a database from which, among other things, it is possible 
to know the incidence (new cases per age, sex, risk factor, geographic location, etc, per 
period of time) of the disease. The availability of such information allows health 
authorities, in principle, to monitor and to plan controlling the disease, for example 
providing early warning of possible outbreaks [2]. 
 
In spite of international, national or local laws, norms or regulations requiring medical 
providers to report notifiable diseases to public health authorities, reporting is almost 
always incomplete [3-8].  This is due to a variety of reasons. First diseases may be 
asymptomatic. For example only around one in five dengue cases are symptomatic [9]. 
Second a case may be symptomatic but an individual may not seek healthcare due to 
mild or self-limiting symptoms or lack of knowledge about when to seek healthcare [4] 
or social stigma due to the nature of the disease, (for example sexually transmitted 
diseases).  Even if an individual seeks healthcare a disease may not be notifiable, or if 
now notifiable may not have been notifiable in the past leading to incomplete 
notification records. A disease may also be misdiagnosed. Finally there may be failures 
in the technical or administrative steps leading to registration [10].  
 
Rosenburg et al. [11] estimated that for every 100 persons infected with Shigella, 76 
become symptomatic, 28 consulted a physician, nine submitted stool samples, seven 
had positive results, six were reported to the local health department and five were 
reported nationally to the Centers for Disease Control and Prevention. Thus they 
proposed a multiplication factor of 20 to estimate the number of Shigella infections 
based on national Shigellosis case reports. 
 
Konowitz, Petrossian and Rose [10] investigated under-reporting of disease and 
knowledge of physicians of reporting requirements at two hospitals in New York City in 
1982. They say that physicians may not know which diseases are reportable or the 
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correct reporting procedures. The percentage of physicians who knew which diseases 
they had to report ranged from 37% for trachoma to 96% for syphilis. The results of 
Konowitz et al. suggest that a major factor in physician under-reporting is lack of 
knowledge of the reporting system. 
 
Brabazon et al. [12] highlighted the extent of under-reporting of notifiable infectious 
disease hospitalisations in a health-board in Ireland, which was felt to be concerning for 
disease surveillance. Under-reporting was definitely demonstrated in 9 out of 22 
notifiable diseases amounting to 572 cases (18% of missed cases). The most missed 
cases were viral meningitis, infectious mononucleosis, unspecified hepatitis C and acute 
encephalitis. 
 
Keramou and Evans [5] performed a systematic review of completeness of infectious 
disease notification in the United Kingdom. Reporting completeness varied from 3% to 
95% and was most strongly correlated with the disease being reported. Median 
reporting completeness was 73% for tuberculosis, 65% for meningococcus disease and 
40% for other diseases. They conclude that reporting completeness remains suboptimal 
even for diseases that are under enhanced surveillance or were of significant public 
health importance. 
 
A review by Doyle et al. [3], limited to published studies conducted in the United States 
between 1970 and 1999, quantitatively assessed infectious disease reporting 
completeness and found that reporting completeness varied from 9% to 99% and was 
strongly associated with the disease being reported. In another study [13] the mean 
reporting completeness for acquired immunodeficiency syndrome, sexually transmitted 
diseases, and tuberculosis as a group was significantly higher (79%) than for all other 
diseases combined (49%).  
 
Schiffman et al. [14] investigated under-reporting of lyme and other tick-borne diseases 
in residents of a high incidence county, Minnesota, USA, in 2009. Of 444 illness events 
352 (79%) were not reported. Of these 102 (29%) meet confirmed or probable 
surveillance case criteria including 91 (26%) confirmed lyme disease cases. 
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Serra et al. [8] developed a universal method to correct under-reporting of 
communicable diseases and applied it to incidence of hydatidosis in Chile, 1985-1994. 
According to this method the real rate of human hydatidosis in the period 1985-1994 
was four times higher than the official notification in the given period. 
 
Rowe and Cowie [6] used data linkage to improve the completeness of Aboriginal and 
Torres Strait Islander status in communicable disease notifications in Victoria, 
Australia. The burden of notifiable diseases in Torres Strait Islander Victorians could 
not be accurately estimated due to under-reporting of indigenous status. There were 
12,488 cases of hepatitis B, hepatitis C (HCV) and gonococcal infection in Victoria in 
2009-2010 with indigenous status missing in 61.6%, 67.8% and 33.1% of those 
conditions, respectively. They used data linkage to improve completeness of indigenous 
status in people notified with viral hepatitis and gonococcal infection. 
 
Of particular concern are those chronic, mainly asymptomatic, infectious diseases that 
allow infected individuals to live for years or even decades without being recognised as 
such. These diseases can represent a heavy burden to the affected populations and pose 
significant risk to the international community. Perhaps the most dramatic examples of 
the latter include human immunodeficiency (HIV) and HCV viruses pandemics. In fact, 
these two infections have been labeled by WHO as the epidemics of the XXth and 
XXIth centuries, respectively [7, 15].  
 
One critical consequence of under-notification of such diseases is the fact that their 
prevalence estimates are frequently way under-estimated, leading to miscalculation of 
their actual burden and making control efforts suboptimal [4]. 
 
HCV is a disease with a long period between infection and symptoms developing. 
Because infected people are mainly asymptomatic and risk behaviour may have 
occurred a long time ago individuals often do not consult health professionals to discuss 
potential disease infection. As in general a large high risk group is people who share 
injection equipment and other injection paraphernalia, for example cookers, filters and 
spoons, and drug injection is an illegal activity, which often does not meet with social 
approval, light to moderate injectors, or past injectors who do not currently inject, may 
not disclose their risky behaviour to their health provider. Being unaware of the risk 
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behaviour the health provider is unable to recommend HCV screening. Also HCV is 
extremely easy to catch via injecting. Past injectors who no longer inject may not 
perceive themselves to be at risk. 
 
In a previous paper [16] we assumed that the infection (HCV) was in steady-state. Then 
we proposed two methods to give a first rough estimate of the actual number of HCV 
infected individuals (prevalence) taking into account the yearly notification rate of 
newly reported infections (incidence of notification) and the size of the Liver 
Transplantation Waiting List (LTWL) of patients with liver failure due to chronic HCV 
infection [17]. Both approaches, when applied to the Brazilian HCV situation converged 
to the same results, that is, the methods proposed reproduce both the prevalence of 
reported cases and the LTWL with reasonable accuracy. In that paper we show how to 
calculate the prevalence of people living with HCV in Brazil, which resulted in a value 
up to 8 times higher than the official reported number of cases [16].  
 
In both [16] and this paper the under-reporting mechanism is included in the model by 
dividing the infected individuals into two categories: notified and non-notified. Newly 
infected individuals enter the non-notified class and leave it either through death, 
recovery or notification. If they are notified they immediately enter the notified infected 
class. 
 
The present paper is an improvement of those techniques because, unlike in the 
previous paper mentioned above, now we do not assume steady state. Unfortunately, 
given the short period of time with data available (hepatitis notification became 
compulsory in Brazil only in 1999 [18], it cannot give more precise information on 
HCV prevalence than the one already provided by our previous study, but it illustrates 
the techniques that allow the prevalence estimation based on age and time of previous 
notifications, and that can be applied to any notifiable disease.  
 
This paper is organised as follows: First we describe a continuous model, that is a 
model where the variables are continuous functions of age and time. Next we describe a 
discrete model, in which the variables are discrete functions of age and time. In the 
following section we discuss application to HCV. Then we turn to our estimation 
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method applied to the size of the Liver Transplantation Waiting List in Brazil. The next 
section gives our numerical results. Discussion and conclusions close the paper. 
Methods 
 
Continuous time and age model 
 
Assume we have an SIR (Susceptible-Infected-Removed) type infection and let 
,  and be the number of individuals with age between 
at time t that are susceptible, infected and removed (or recovered), 
respectively. In addition, as mentioned in the Background section, public health 
authorities demand that some diseases be compulsorily notifiable, that is they publish 
the number of diagnosed individuals per time unit for each age interval (incidence) in 
public databases. Therefore, we can divide the prevalence of infected individuals into 
two classes: notified individuals, denoted , and non-notified individuals, 
denoted . 
 
Let be the so-called age and time-dependent force-of-infection (incidence 
density). Then: 
 
                                                                                                        (1) 
 
is the number of susceptible individuals who get the infection when aged between 
 during the time interval . Standard arguments allow us to write the 
following system of partial differential equations, known as Trucco-Von Foester 
equations in the literature [19] : 
 ߲ܵ(ܽ, ݐ)߲ݐ + ߲ܵ(ܽ, ݐ)߲ܽ = െߣ(ܽ, ݐ)ܵ(ܽ, ݐ) െ ߤ(ܽ, ݐ)ܵ(ܽ, ݐ),                                                           ߲ܫேே(ܽ, ݐ)߲ݐ + ߲ܫேே(ܽ, ݐ)߲ܽ = ߣ(ܽ, ݐ)ܵ(ܽ, ݐ)                                                                             (2)   െ൫ߤ(ܽ, ݐ) + ߙேே(ܽ, ݐ) + ߛேே(ܽ, ݐ)൯ܫேே(ܽ, ݐ) െ ߢ(ܽ, ݐ)ܫேே(ܽ, ݐ), ߲ܫே(ܽ, ݐ)߲ݐ + ߲ܫே(ܽ, ݐ)߲ܽ =  ߢ(ܽ, ݐ)ܫேே(ܽ, ݐ) െ ൫ߤ(ܽ, ݐ) + ߙே(ܽ, ݐ) + ߛே(ܽ, ݐ)൯ܫே(ܽ, ݐ),   
 
dataS ),( dataI ),( dataR ),(
daaa  and 
dataI N ),(
dataI NN ),(
),( taO
dadttaSta ),(),(O
daaa  and dt
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 ߲ܴ(ܽ, ݐ)߲ݐ + ߲ܴ(ܽ, ݐ)߲ܽ =  ߛேே(ܽ, ݐ)ܫேே(ܽ, ݐ) + ߛே(ܽ, ݐ)ܫே(ܽ, ݐ) െ ߤ(ܽ, ݐ)ܴ(ܽ, ݐ),
 
 
where the meaning of the parameters is described in Table 1. 
 
Table 1. Parameters used in model (2).   
Parameter Meaning Values used in the  
numerical simulation 
 
Force of Infection Calculated 
 Natural Mortality Rate 0.0133 year-1* 
 
Disease-induced Mortality Rate  
for non-notified individuals 
** 
 
Disease-induced Mortality Rate  
for notified individuals 
** 
 
Recovery Rate  
for non-notified individuals 
Assumed negligible 
 
Recovery Rate  
for notified individuals 
Assumed negligible 
 Notification Rate 0.0125 [16] 
   * From demographic data of Brazil.  
  ** Constructed as equal to 0.15/{1 + exp(ʷ0.1(a ʷ 57.31))} yearsʷ1 as in  [16] . 
  
 
In Table 1, we neglected the value of the recovery rates in the numerical simulations 
because we assumed that HCV infection is very long-lasted. These parameters, 
however, were included in the model for the sake of completeness. 
 
The notification rate ߢ(ܽ, ݐ) is one of the most important parameters in the model. This 
represents the rate at which those non-notified individuals of age a are reported to health 
authorities and notified. This has two components, first the rate of an infected person 
being recognised and secondly the rate of being reported. So if ߢ(ܽ, ݐ) is small then 
there will be a large number of non-notified infected individuals hidden from the 
system, whereas if ߢ(ܽ, ݐ) is large then most infected individuals will be notified and 
the records will accurately reflect the number infected in the population. 
 
The solution of system (2) can be obtained with the method of characteristics [19]. 
However, for our purposes, it is better to solve the equation by following a cohort, as 
described in [20].  
 
The solution of the equation for susceptible individuals is: 
),( taO
),( taP
),( taNND
),( taND
),( taNNJ
),( taNJ
),( taN
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 ܵ(ܽ, ݐ଴ + ܽ) = ܵ(0, ݐ଴)expቆെන [ߣ(ݏ, ݐ଴ + ݏ) + ߤ(ݏ, ݐ଴ + ݏ)]݀ݏ௔଴ ቇ .                           (3)  
 
There are a small number of maternal-infant HCV infections [21]. It would be possible 
to include these in the theoretical model. However data for age zero is not used in the 
calculations because it is unreliable. So to include maternal-infant HCV infections 
would make the model more complicated but not change the numerical results. So we 
ignore these maternal-infant HCV infections. 
 
The solution for the equation for infected individuals is: 
 ܫேே(ܽ, ݐ଴ + ܽ) = න ߣ(ݏ, ݐ଴ + ݏ)௔଴ ܵ(ݏ, ݐ଴ + ݏ)                                                                               
exp൫െ׬ [ߤ(ݔ, ݐ଴ + ݔ) + ߛேே(ݔ, ݐ଴ + ݔ) + ߙேே(ݔ, ݐ଴ + ݔ) + ߢ(ݔ, ݐ଴ + ݔ)]݀ݔ௔௦ ൯ ݀ݏ,  (4) ܫே(ܽ, ݐ଴ + ܽ) = න ߢ(ݏ, ݐ଴ + ݏ)௔଴ ܫேே(ݏ, ݐ଴ + ݏ)                                                                             
                                exp൫െ׬ [ߤ(ݔ, ݐ଴ + ݔ) + ߛே(ݔ, ݐ଴ + ݔ) + ߙே(ݔ, ݐ଴ + ݔ)]݀ݔ௔௦ ൯ ݀ݏ.   (5) 
 
Finally, the equation for the removed individuals is given by: ܴ(ܽ, ݐ଴ + ܽ) = න ൫ߛேே(ݏ, ݐ଴ + ݏ)ܫேே(ݏ, ݐ଴ + ݏ) +  ߛே(ݏ, ݐ଴ + ݏ)ܫே(ݏ, ݐ଴ + ݏ)൯௔଴                
                                                                                              exp൫െ׬ [ߤ(ݔ, ݐ଴ + ݔ)]݀ݔ௔௦ ൯ ݀ݏ.   (6) 
 
Assuming steady state, the system (1) was solved by Amaku et al. [16] to calculate the 
prevalence of HCV in Brazil. The work that follows is an extension of the methods 
described there and its results are in accordance with the previous results for the cases 
where real data are available. 
 
Discrete time and age model 
 
In real life epidemics notification is discrete with the time and age units expressed in 
weeks, months or years. Hence, in order to apply the model to a real public health 
problem we discretised model (2), with time and age unit expressed in years. This 
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discretisation has to be done carefully to use the maximum advantage of the data 
available. 
 
Calculating the prevalence INN*{A,i} and IN*{A,i} 
 
To avoid potential confusion between similar variables in the discrete and continuous 
models we adopt the convention that discrete variables have a ‘*’ superscript after the 
variable and their arguments are in curly parentheses,{}, whereas continuous variables 
do not have a ‘*’ superscript after the variable and their arguments are in round 
parentheses (). 
 
From the SINAN database we can calculate SINAN*{A,i} where A is an integer number 
and i represents a calendar year, which represents the number of infected individuals 
notified to SINAN in the calendar year i, who at the end of calendar year i have age A 
years (in other words at the end of calendar year i their exact age a is in the time interval 
[A,A+1)).  
 
Because we want the variables in the discrete model to relate to the SINAN data we 
similarly define INN*{A,i} and IN*{A,i} to denote respectively the number of non-
notified infected and notified infected individuals at time the end of calendar year i, 
whose age at that time is A years (so their exact age lies in [A,A+1)). Given parametric 
functions such as ߢ(ܽ, ݐ) and ߶ேே(ܽ, ݐ) in the continuous model, in the corresponding 
discrete model these are assumed to be discrete functions ߢௗ(ܽ, ݐ) =  ߢ஺,௜  and ߶ௗேே(ܽ, ݐ) = ߶஺,௜ேே for (a,t) א R={a א [A, A+1) and t א (ti-1, ti]}. Here ti denotes the end 
of calendar year i, and ߢ஺,௜ and ߶஺,௜ேே are respectively the average values of ߢ(ܽ, ݐ) and ߶ேே(ܽ, ݐ) over the region R. 
 
The discretised versions of equations (4) and (5) are given by equations (7) and (8) 
below, which are approximations as explained in the Appendix. ܫேேכ{ܣ, ݅} = ܫேேכ{ܣ െ 1, ݅ െ 1}exp ൤െ1
2
൫ߢ஺ିଵ,௜ + ߢ஺,௜ + ߶஺ିଵ,௜ேே + ߶஺,௜ேே൯൨ 
                              +ܫܰܥ{ܣ, ݅},                                                                                      (7) 
where for A=0, ܫேேכ{ܣ െ 1, ݅ െ 1} = 0. ܫܰܥ{ܣ, ݅} is the new HCV cases occurring 
between times ti-1 and ti that are still alive, infectious and non-notified at time ti in the 
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year cohort born between times ti-A-1 and ti-A. Here (using the continuous model 
notation) ߶ேே(ܽ, ݐ) = ߤ(ܽ, ݐ) + ߛேே(ܽ, ݐ) + ߙேே(ܽ, ݐ). 
 In equation (7), the term 
exp ൤െ1
2
൫ߢ஺ିଵ,௜ + ߢ஺,௜ + ߶஺ିଵ,௜ேே + ߶஺,௜ேே൯൨ 
means the probability of not being removed from the non-notified class of individuals, 
either by natural death, disease-induced death, recovery or notification in the interval  
(ti-1,ti]. Equation (7) is very important because, as shown later in the paper, it allows 
the calculation of the true incidence from empirical data (see equation (12) below). 
 
Recurrence equation (7) can be solved by well-known methods and the prevalence of 
notified and non-notified individuals can be estimated (see equations (13) and (14) 
below). 
  
Similarly, we can write: ܫேכ{ܣ, ݅} = ܫேכ{ܣ െ 1, ݅ െ 1}exp ൤െ1
2
൫߶஺ିଵ,௜ே + ߶஺,௜ே ൯൨                                                      
                                  +׬ ܱܰܶܫܨܫܥܣܶܫܱܰ(ܽ, (ݐ௜ െ 1, ݐ௜])݀ܽ,஺ାଵ஺                                   (8) 
 
where (again using the continuous model notation) ߶ே(ܽ, ݐ) = ߤ(ܽ, ݐ) + ߛே(ܽ, ݐ) +ߙே(ܽ, ݐ). The last term represents the notifications of HCV between times ti-1 and ti of 
individuals in the year cohort born in ti-A-1 to ti-A who are still in the notified class at 
time ti, i.e. 
 න න ߢௗ(ܽ െ 1 + ݔ, ݐ௜ െ 1 + ݔ)ܫேே(ܽ െ 1 + ݔ, ݐ௜ െ 1 + ݔ)                                              ଵ଴஺ାଵ஺  
                                                        exp ቈെන ߶ௗே(ܽ െ 1 + ݖ, ݐ௜ െ 1 + ݖ)ଵ௫ ݀ݖ቉ ݀ݔ ݀ܽ, 
                                                   ൎ  ߢௗ ቀܣ + ଵଶ , ݐ௜ቁ ܫேே ቀܣ + ଵଶ , ݐ௜ቁ.                                           (9) 
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This is because both integration intervals are of length one, hence to first order we can 
approximate the integrand by its value at any specific point in the integrated area. So we 
choose ܽ = ܣ + ଵଶ, x=1. Now note that 
(i) ߢௗ ቀܣ + ଵଶ , ݐ௜ቁ =  ߢ஺,௜, as in the discrete model ߢௗ(ܽ, ݐ) = ߢ஺,௜ over the region 
R={a א [A, A+1) and t א (ti-1, ti]}, 
and 
(ii) ܫேேכ{ܣ, ݅}  ൎ ܫேே ቀܣ + ଵଶ , ݐ௜ቁ, 
as explained in the Appendix (equation (A5)). Hence the last term in (8) is 
                න ܱܰܶܫܨܫܥܣܶܫܱܰ(ܽ, (ݐ௜ െ 1, ݐ௜])݀ܽ ൎ ߢ஺,௜ ܫேேכ{ܣ, ݅}.                            (10)஺ାଵ஺  
In the next section, we are going to show how to solve equations (7) and (8) using the 
notified cases in a particular setting, namely HCV in Brazil. Using the notified 
incidences and good guesses for the mortality rates we can calculate any desired 
properties of the infected population. In the next section we calculate the prevalence of 
the disease. The calculation presented applies to any notifiable infectious disease. 
 
Example of Application: Hepatitis C 
 
In this section we exemplify the above theory by calculating the prevalence of HCV, a 
flaviviral infection that afflicts close to 3% of the world population [22], in Brazil. As 
mentioned in the Introduction, the great majority of infections with HCV, however, are 
not easily identified and, therefore, frequently non-notified. Our data were taken from 
the National Reportable Disease Information System  "Sistema de Informação de 
Agravos de Notificação" (SINAN) of the Brazilian Health Ministry [23].  SINAN is 
publicly available through the internet and used by the World Health Organisation [24]. 
It is used throughout Brazil, in all health institutions whether public or private. All 
Brazilians diagnosed with HCV are reported to SINAN. The database includes 
symptomatic patients who report to a doctor, also symptomatic individuals picked up 
through screening for blood banks or other means. The individuals are diagnosed and 
then the diagnosis is confirmed via an HCV antibody test. Figure 1 shows the time and 
age variation in the reported number of HCV cases in Brazil. 
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In fact, the actual number of reported HCV infections is available only from 2000 
onward. As we know from previous studies [25], HCV was introduced in Brazil in the 
later 1950s. We therefore constructed the number of reported with a sigmoidal decay 
backwards until 1932, as argued below. We used this artifice only to illustrate the model 
and these figures have little epidemiological significance, as argued below. We shall 
return to this point in the results section, where we explain this procedure in more detail. 
 
Figure 1 here 
 
 
 
 
Estimating the total number of HCV infected individuals in Brazil 
 
Recall that SINAN*{A,i} is the number of individuals aged A to A+1 at time ti who were 
notified to SINAN in the current year i, (ti-1,ti]. Now  
                                           SINAN*{A,i} ൎ ߢ஺,௜ܫேேכ(ܣ, ݅).                                       (11) 
This approximation is obtained by using equation (10) as 
                        SINAN*{A,i}=׬ ܱܰܶܫܨܫܥܣܶܫܱܰ(ܽ, (ݐ௜ െ 1, ݐ௜])݀ܽ.  ஺ାଵ஺  
As HCV infection is determined by taking an antibody test it is not possible to 
distinguish between individuals protected by maternal antibodies from HCV infected 
individuals. Hence we do not use the data for A=0 as it is unreliable, instead we take                                           
SINAN*{0,i} = 0, for all i. Because only a very small number of individuals of age 0 are 
infected this does not cause significant error in the estimation.  
 
From (7) and (11) we can write down the fundamental equation for estimating the 
incidence, for ܣ ൒ 0: ܫܰܥ{ܣ, ݅} = ܵܫܰܣܰכ{ܣ, ݅}ߢ஺,௜                                                                                                              
                െ  ܵܫܰܣܰכ{ܣ െ 1, ݅ െ 1}ߢ஺ିଵ,௜ିଵ exp ൜െ12 ൫ߢ஺ିଵ,௜ + ߢ஺,௜ + ߶஺ିଵ,௜ேே + ߶஺,௜ேே൯ൠ ,      (12) 
where SINAN*{0,i} and SINAN*{-1,i} are interpreted as zero for all i.  
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Note that, as observed in equation (12), the method consists of subtracting consecutive 
values of a diagonal of a matrix containing age in lines and time in columns. In some 
instances, however, it may happen that for certain ages and years the calculated 
incidence is negative. Our interpretation is that, for that particular age and time, the 
notified incidence was zero. When this happened in the actual calculation we assigned 
the value zero to the notification incidence.  
 
Therefore, INN*{A,i} can be calculated for each age and time reported as ܫேேכ{ܣ, ݅} = ෍ܫܰܥ{ܣ െ ݆, ݅ െ ݆}஺௝ୀ଴                                                                                             
                    expቐെ1
2
෍൫ߢ஺ିଵି௣,௜ି௣ + ߢ஺ି௣,௜ି௣ + ߶஺ିଵି௣,௜ି௣ேே + ߶஺ି௣,௜ି௣ேே ൯௝ିଵ௣ୀ଴ ቑ .      (13) 
Similarly, for IN*{A,i}, we have: 
  ܫேכ{ܣ, ݅} = ෍ܵܫܰܣܰכ{ܣ െ ݆, ݅ െ ݆}஺௝ୀ଴ expቐെ 12෍൫߶஺ିଵି௣,௜ି௣ே + ߶஺ି௣,௜ି௣ே ൯௝ିଵ௣ୀ଴ ቑ  . (14) 
                                                                                                                                        
Figure 2 shows the calculation of ܫܰܥ{ܣ, ݅} using equation (12) with the SINAN data as 
shown in Figure 1. 
 
The Size of the Liver Transplantation Waiting List in Brazil 
 
It is known that a fraction of those individuals infected with HCV evolve to liver failure 
after many years of infection [26]. Let us denote those individuals diagnosed with liver 
failure of whose age in whole years is A at the end of calendar year i, time ti as ܮܨ{ܣ, ݅}. 
These individuals have been necessarily diagnosed with HCV and, therefore, are a 
fraction of the notified infected 
Figure 2 here                                             
individuals IN*{A,i}. It is assumed that individuals develop liver failure after a minimum 
time interval ߬௠௜௡, say 10 years. From equation (8) for IN*{A,i} we obtain the equation 
for ܮܨ{ܣ, ݅}: ܮܨ{ܣ, ݅} =  ෍ ߟ஺ିఛ஺ఛୀఛ೘೔೙ ܫேכ{ܣ െ ߬, ݅ െ ߬}expቐെ12 ቎෍൫߮஺ିଵି௣,௜ି௣ே + ߮஺ି௣,௜ି௣ே ൯ఛିଵ௣ୀ଴ ቏ቑ,          
15 
 
                                                                                                                                                     (15) 
where is a discretised function that decreases from ߬ = ߬௠௜௡  up until ߬ = ܣ, 
representing the rate at which infected (and notified) individuals of age A-Ĳ develop 
liver failure.  
 
We know that liver damage (whether due to HCV or some other cause) is a progressive 
disease [27, 28] so the longer that an individual has been infected the more liver damage 
they will have sustained and the greater the chance of liver failure. Given a group of 
individuals currently all of age A those that have been in the database longer are also 
more likely to have been infected for longer. Hence, , the liver failure rate of those 
of current age A who were notified to the database ߬ years ago should increase with ߬. 
Since early symptoms of liver disease precede complete failure it is reasonable to 
assume that there is a minimum gap between notification and liver failure. 
 
Summing up over all ages we obtain the size of ܮܨ{݅}, which is the total number of 
individuals with liver failure at time ti: ܮܨ{݅} = ෍ ෍ ߟ஺ିఛ஺ఛୀఛ೘೔೙ ܫேכ{ܣ െ ߬, ݅ െ ߬}expቐെ12 ቎෍൫߮஺ିଵି௣,௜ି௣ே + ߮஺ି௣,௜ି௣ே ൯ఛିଵ௣ୀ଴ ቏ቑ ,஺೘ೌೣ஺೘೔೙   
                                                                                                                                       (16) 
where Amin and Amax are minimum and maximum ages. Apart from those individuals 
who are transplanted (see below) ܮܨ{݅} corresponds to the Liver Transplantation 
Waiting List (LTWL). 
 
Let us now rewrite equation (16) considering transplantation. Let ߰(ܽ, ݐ) be the 
transplantation rate of individuals of aged a א [A, A+1) in calendar year t א (ti-1, ti]. 
Then, equation (16) becomes 
 ܮܹܶܮ{݅} = ෍ ෍ ߟ஺ିఛ஺ఛୀఛ೘೔೙ ܫேכ{ܣ െ ߬, ݅ െ ߬}                                                                           ஺೘ೌೣ஺೘೔೙  
                         expቐെ 1
2
቎෍൫߮஺ିଵି௣,௜ି௣ே + ߮஺ି௣,௜ି௣ே + ߰஺ିଵି௣,௜ି௣ே + ߰஺ି௣,௜ି௣ே ൯ఛିଵ௣ୀ଴ ቏ቑ .  (17) 
The number of transplants in calendar year i is then given by TR{i} where
                          
 
WK A
WK A
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 ܴܶ{݅} = ෍ ෍ ߰஺,௜ ߟ஺ିఛ஺ఛୀఛ೘೔೙ ܫேכ{ܣ െ ߬, ݅ െ ߬}                                                                          ஺೘ೌೣ஺೘೔೙  
                          expቐെ1
2
቎෍൫߮஺ିଵି௣,௜ି௣ே + ߮஺ି௣,௜ି௣ே + ߰஺ିଵି௣,௜ି௣ே + ߰஺ି௣,௜ି௣ே ൯ఛିଵ௣ୀ଴ ቏ቑ . (18) 
We take for ߰஺,௜  a suitably truncated bell-shaped discrete function [26] with a 
maximum at 45 years of age for all i. 
 
 
 
Results  
 
One of our objectives is to calculate equations (13) and (14) in order to obtain the 
estimated prevalence of notified and non-notified HCV infections which sum up to total 
prevalence. Unfortunately, the data available are restricted to the period between 2000 
and 2012. In order to simulate a longer history of HCV infection in Brazil, we 
artificially constructed such a previous history by extrapolating backwards. First, we 
averaged the notified cases in the period between 2000 and 2012. Then, we fitted a 
sigmoidal-shaped curve representing the notified cases back for the period between 
1932 and 2000. We did that for all ages such that the age distribution of notified cases 
was assumed fixed for all the extrapolated periods. We are well aware that HCV was 
probably introduced in Brazil in the 1950's and, therefore, this calculation is only an 
exercise to illustrate the method. 
 
In a previous paper [16], this extrapolation was done differently. We assumed the 
disease to be in steady state until 1932. The results of this previous calculation are 
therefore different from the ones presented in this paper. We shall elaborate on this 
later. To begin with, Figure 3 shows a preliminary result on this direction. The 
continuous line is the total prevalence extrapolating the data as if in steady state [16]. 
The sigmoid dotted line is the total prevalence calculated assuming the artificially 
constructed notification as explained above. 
 
Figure 3 here 
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Results of the numerical calculations are summarised in Table 2. In it we compare the 
prevalence in 2012 of HCV infected individuals who have been reported to SINAN 
until 2012 with the outcomes of the model. In Figure 4 we also compare the size of the 
Liver Transplantation Waiting List according to the official figures with the outcomes 
of the model. 
 
Amaku et al. [16] assumed a stationary situation so time dependence was removed from 
the equations. A system of differential equations was used to describe the densities with 
respect to age of susceptibles, reported individuals, non-reported individuals and 
recovered individuals. One parameter was the disease reporting rate ߢ. They used two 
methods. 
 
In the first method it was assumed that the age-dependent force of infection ߣ(ܽ) has a 
Gaussian shape with three scaling parameters. For a given value of ߢ the force of 
infection was used in the differential equations and was parametrically fitted to the age-
dependent SINAN incidence data. The value of ߢ was then fitted heuristically to both 
the full age and time dependent SINAN data and the length of the LTWL. The fitted 
values of both ߣ(ܽ) and ț were then used to find the total notified and non-notified 
HCV incidence data. 
 
In the second method a different parametric function was fitted to the age-dependent 
SINAN incidence data. Given a value of ț they next used the differential equations to 
model the incidence. Again the value of ț was then fitted heuristically to both the full 
age and time dependent data and the length of the LTWL. The final fitted values of ț 
and the SINAN age-dependent incidence data were used to find the total notified and 
non-notified HCV incidence data. 
 
Table 2. Summary of the Results 
RESULTS Current Method 
First Method of  
[16]  
Second Method of 
[16] 
Prevalence of Notified HCV Infections 
 
163,902* 
 
169,382** 
 
- 
240,120# 
- 
227,074# 
Prevalence of Non-Notified HCV in Brazil 
 
1,433,638* 
 
1,446,771** 
 
- 
1,650,100# 
- 
1,632,300# 
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Total Prevalence of HCV in Brazil 
 
1,597,540* 
 
1,616,153** 
 
 
- 
1,890,220# 
- 
1,859,374# 
*Using only the official SINAN period (2000-2012) assuming zero notification incidence for all years and ages from 
2000 backwards until 1932.  
** Calculated from real data (2000-2012) and extending the data backwards assuming a sigmoidal decay until 1932. 
# Taking the average number of cases reported annually to SINAN between 2004 and 2012, a period in which a 
steady state could be assumed. 
 
The corresponding results, called the first method and second method in Table 2, were 
obtained using the following procedure. First, we assumed that the infection was in 
steady state from 2004 to 2012 and averaged the reported incidence. This reported 
incidence was extrapolated backwards until 1932. It is therefore not surprising that the 
published numbers in [16] including the third and fourth columns of Table 2 are larger 
than the figures obtained in this paper. The difference represents up to a certain point 
the state of the infection prior to 2000 and from this point of view the results seem to be 
consistent with what was believed about the infection in Brazil. 
 
From the results of the current method expressed in Table 2 it is possible to observe that 
the difference between taking into account the constructed data backwards until 1932 
and the official SINAN period of 2000-2012, reflects the significant contribution of this 
period to both the SINAN and the total prevalence of HCV in Brazil. Note that the 
artificially constructed incidence will manifest itself for individuals older than 40 years. 
 
Figure 4 shows the comparison between the actual size of the LTWL as in [17] Chaib et 
al. (2014) and the result of the application of equation (17). The parameter ߢ was 
obtained in [16] by fitting the model to the LTWL. All other parameters were obtained 
independently of the LTWL. Figure 4 shows that using just this one fitted parameter the 
model accurately reproduces the whole LTWL time series. So we can assess the model 
as being reasonably accurate. 
 
Figure 4 here 
 
 
Discussion 
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This paper is an attempt to provide a method to estimate the actual number of infected 
individuals (and other parameters related to transmission) of compulsory notifiable 
infectious diseases from the officially notified number of cases. Considering that, in the 
great majority of cases, the number of notified cases represents only a small but variable 
fraction of the total number of infected individuals, a reliable method of estimating the 
latter from the former can represent an important tool for public health policies. 
Notwithstanding the recognised importance of under-notification of most chronic 
infections, the tools to deal with this information gap proposed so far are varied and, to 
the best of our knowledge, there is currently no consensus about which is or are the 
most appropriate [3-8]. 
 
In a previous publication [16], a continuous time-dependent model for the estimation of 
the total number of HCV infected individuals in Brazil was proposed. In that paper, we 
assumed a steady state for the period between 2004 and 2012, and we concluded that the 
non-notified to notified ratio in the number of infections was about 7 to 1. The current 
work is an extension of that paper and we relaxed the steady state assumption. To do a 
calculation for individuals with age up to 80 years, we artificially extended the official 
notification database backwards from the year 2000 back to 1932. This artificially 
constructed database was intended only to illustrate the method. In addition, we 
discretised the variables time and age both because the notification database presents the 
number of cases per year and because the discrete model is easier to be implemented, 
both mathematically and computationally, than the continuous age and time 
corresponding model. 
 
HCV is recently becoming virtually a 100%-curable disease due to antiviral treatments 
such as Ledipasvir/Acetonate/Sofosbuvir and others. So, there will be fewer and fewer 
individuals waiting for liver transplantation because of that. It is straightforward to 
modify the theoretical model to take account of this. If we have data on age, treatment 
and cure rates of individuals, let ߦ(ܽ, ݐ) denote the rate at which notified infectious 
individuals of age a are given treatment and cured at time t. Then in the continuous 
model (2) in the first partial differential equation for S(a,t) there is an extra term 
                                                        +ߦ(ܽ, ݐ)ܫே(ܽ, ݐ) 
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corresponding to infectious, notified, treated individuals who are cured and in the third 
partial differential equation of (2) for ܫே(ܽ, ݐ) the term െ൫ߤ(ܽ, ݐ) + ߙே(ܽ, ݐ) + ߛே(ܽ, ݐ)൯ ܫே(ܽ, ݐ) 
becomes െ൫ߤ(ܽ, ݐ) + ߙே(ܽ, ݐ) + ߛே(ܽ, ݐ) + ߦ(ܽ, ݐ)൯ ܫே(ܽ, ݐ), 
so  ߶ே(ܽ, ݐ) becomes 
     ߶ே(ܽ, ݐ) = ߤ(ܽ, ݐ) + ߛே(ܽ, ݐ)+ ߙே(ܽ, ݐ) + ߦ(ܽ, ݐ). 
Thus it is straightforward to model antiviral treatment. 
 
The method presented in this paper is applicable to any compulsory notifiable infectious 
disease provided that one has information about at least two end-points of the natural 
history of the disease of interest, or carrying out an alternative diagnostic test in a 
representative sample of the affected population. For instance, for the case of HCV, we 
used the number of notified cases and the size of the Liver Transplantation Waiting List. 
For other diseases, in which one has only the number of notified cases, an alternative to 
the Liver Transplantation Waiting List depends on the disease one is interested in. For 
instance, for the case of dengue in a sufficiently small region, an age-dependent 
seroprevalence profile of a properly designed sample of the population would be 
sufficient. For infections like HIV, in addition to the reported number of cases, a sample 
representing each group of risk should be used. 
 
The method demonstrated to be accurate in retrieving the number of infected individuals 
for the case of HCV as it fits the Liver Transplant Waiting List data (see Figure 4) and 
the results are in good accordance with the previous estimations by Amaku et al. [16].  
 
We have already said that the notification rate is the most important parameter in the 
model. This could be improved by various methods, for example public education about 
risk factors for HCV such as injecting drug use and new treatments, publicity 
campaigns, or screening programs, either of the general public or targeted high risk 
populations. Most important, however, would be a population-based seroprevalence 
study that could unequivocally determine individuals previously infected by HCV. The 
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ratio of notified individuals to seropositive ones would determine the actual value of 
notification rate (ߢ).   
 
In spite of its accuracy and simplicity, the method here presented has some important 
limitations that are worthwhile mentioning. Firstly, the model is data-greedy in the 
sense that a long time series of notified cases is necessary for the calculations. 
Secondly, the model has a large number of parameters whose values are not known with 
any precision for the great majority of cases. For example, as the model deals with long 
time series, demographic parameters such as the natural mortality rate are crucial for the 
calculations.  
 
Notwithstanding those limitations, the model has the advantage that it can predict 
quantities that can be iteratively used to improve it. For instance, for HCV the model 
allows the calculation of the proportion of individuals that have the infection for Wyears, 
that is the age of infection. If this can be checked from information from patients (e.g., 
blood transfusion time), the model can be improved immediately. This is thoroughly 
explained in [16] Amaku et al. (2016). 
 
Conclusions 
We can conclude that the model proposed in this paper can be useful for estimation of 
the actual magnitude of endemic states of infectious diseases, particularly for those 
where the number of notified cases is only the tip of the iceberg. In addition, the method 
can be applied to other situations, such as the well-known under-reported incidence of 
criminality (for example rape), among others. 
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In this Appendix, we deduce the equation (7) from the main text. Let us define the 
function , which is a function that expresses the evolution of a cohort. 
Then  ݀݀ݔ [ܫேே(ܽ + ݔ, ݐ + ݔ)] = ߣௗ(ܽ + ݔ, ݐ + ݔ) ܵ(ܽ + ݔ, ݐ + ݔ)                                                     
                                                െ[ߢௗ(ܽ + ݔ, ݐ + ݔ) + ߶ௗேே(ܽ + ݔ, ݐ + ݔ)]ܫேே(ܽ + ݔ, ݐ + ݔ) , 
                                                                                                                                      (A1) 
where 
         ߶ௗேே(ܽ + ݔ, ݐ + ݔ) = ߤௗ(ܽ + ݔ, ݐ + ݔ) + ߛௗேே(ܽ + ݔ, ݐ + ݔ) + ߙௗேே(ܽ + ݔ, ݐ + ݔ). 
 
Multiplying both sides by exp ቂ׬ ቀߢௗ(ܽ + ݖ, ݐ + ݖ) + ߶ௗேே(ܽ + ݖ, ݐ + ݖ)ቁ݀ݖ௫଴ ቃ, we have
 
 
 ݀݀ݔ ቈexp ቈන ቀߢௗ(ܽ + ݖ, ݐ + ݖ) + ߶ௗேே(ܽ + ݖ, ݐ + ݖ)ቁ݀ݖ௫଴ ቉ ܫேே(ܽ + ݔ, ݐ + ݔ)቉ =                  
   ߣௗ(ܽ + ݔ, ݐ + ݔ) ܵ(ܽ + ݔ, ݐ + ݔ) exp ቈන ቀߢௗ(ܽ + ݖ, ݐ + ݖ) + ߶ௗேே(ܽ + ݖ, ݐ + ݖ)ቁ݀ݖ௫଴ ቉. 
                                                                                                                                    (A2) 
So integrating we deduce that ܫேே(ܽ, ݐ) =  ܫேே(ܽ െ 1, ݐ െ 1)                                                                                          (A3) 
                     exp ቈെන {ߢௗ(ܽ െ 1 + ݖ, ݐ െ 1 + ݖ) + ߶ௗேே(ܽ െ 1 + ݖ, ݐ െ 1 + ݖ)}݀ݖଵ଴ ቉ 
                     +׬ ߣௗଵ଴ (ܽ െ 1 + ݔ, ݐ െ 1 + ݔ)ܵ(ܽ െ 1 + ݔ, ݐ െ 1 + ݔ) 
                       exp ቈെන {ߢௗ(ܽ െ 1 + ݖ, ݐ െ 1 + ݖ) + ߶ௗேே(ܽ െ 1 + ݖ, ݐ െ 1 + ݖ)}݀ݖଵ௫ ቉ ݀ݔ. 
The first term corresponds to non-notified individuals ages a-1 at time t-1 who remain 
infectious and non-notified at time t (when their age is a). The second term which we 
denote 
                                                 INCIDENCE(a,(t-1,t]) 
is the density with respect to age a of the incidence of HCV in the cohort of individuals 
born at time t-a which occurs in the time interval (t-1,t] and is still infectious and not 
notified at time t.  
 
),( xtxaI NN 
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Now, INN*{A,i}, the absolute number of infectious non-notified individuals of age in the 
interval [A,A+1) at time ti,  
                                                                  = ׬ ܫேே(ܽ, ݐ௜)݀ܽ,஺ାଵ஺                                          (A4) 
                                                                  ൎ ܫேே ቀܣ + ଵଶ , ݐ௜ቁ,                                              (A5) 
taking the midpoint as an approximation. 
 
Now from (A3) and (A4) 
INN*{A,i}  =׬ ܫேே(ܽ െ 1, ݐ௜ െ 1)஺ାଵ஺  
                   exp ቈെන {ߢௗ(ܽ െ 1 + ݖ, ݐ௜ െ 1 + ݖ) + ߶ௗேே(ܽ െ 1 + ݖ, ݐ௜ െ 1 + ݖ)}݀ݖଵ଴ ቉ ݀ܽ 
                                 +׬ ܫܰܥܫܦܧܰܥܧ(ܽ, (ݐ௜ െ 1, ݐ௜])݀ܽ,஺ାଵ஺                                           (A6) 
where for ܽ ൑ 0, ܫேே(ܽ, ݐ) is interpreted as zero. The last term in (A6), which we shall 
denote INC{A,i}, represents the incidence between times ti-1 and ti of HCV that is still 
infectious and not notified at time ti, in the cohort born between times ti-A-1 and ti-A. In 
the first term in (A6) again for the a-integration we take a=A+ଵଶ as an approximation, as 
the integration interval has length one.  ܫேேכ{ܣ, ݅} ൎ ܫேே ൬ܣ െ 1
2
, ݐ௜ െ 1൰                                                                                                   
                       exp ቈെන ൜ߢௗ ൬ܣ െ 1
2
+ ݖ, ݐ௜ െ 1 + ݖ൰ + ߶ௗேே ൬ܣ െ 12 + ݖ, ݐ௜ െ 1 + ݖ൰ൠ ݀ݖଵ଴ ቉ 
                                                                                                                         +INC{A,i}. 
              = ܫேே ൬ܣ െ 1
2
, ݐ௜ െ 1൰                                                                                              
                  exp ቈെන ൜ߢௗ ൬ܣ െ 1
2
+ ݖ, ݐ௜൰ + ߶ௗேே ൬ܣ െ 12 + ݖ, ݐ௜൰ൠ ݀ݖଵ଴ ቉ + ܫܰܥ{ܣ, ݅}, 
as ߢௗ ቀܣ െ ଵଶ + ݖ, ݐቁ and ߶ௗேே ቀܣ െ ଵଶ + ݖ, ݐቁ are the same for ݐ א (ݐ௜ െ 1, ݐ௜].  
       ൎ ܫேேכ{ܣ െ 1, ݅ െ 1}exp ൤െ1
2
ቀߢ஺ିଵ,௜ + ߢ஺,௜ + ߶ேே஺ିଵ,௜ + ߶ேே஺,௜ቁ൨ 
                                                                                                                         +INC{A,i}, 
because 
(i) Noting that year i-1ends at time ti-1 we have 
                 ܫேே ቀܣ െ ଵଶ , ݐ௜ െ 1ቁ ൎ ܫேேכ{ܣ െ 1, ݅ െ 1},                         by (A5).     
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      (ii) for ݖ א ቂ0, ଵଶቁ,  ߢௗ ቀܣ െ ଵଶ + ݖ, ݐ௜ቁ =  ߢ஺ିଵ,௜ and for ݖ א ቂଵଶ , 1ቃ , ߢௗ ቀܣ െ ଵଶ + ݖ, ݐ௜ቁ =
 ߢ஺,௜.               
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Legends to the Figures: 
 
Figure 1. Time and Age variation of the reported number of HCV infections in Brazil, 
artificially constructed by extrapolating backwards until 1932. 
 
Figure 2. Calculation of ࡵࡺ࡯{࡭, ࢏} from the SINAN data as shown in Figure 1. 
Figure 3. Comparison of the total prevalence calculated according to Amaku et al. [16] 
(continuous line) and assuming the notification as a sigmoidal extrapolation (dotted line). 
 
Figure 4. Comparison between the empirical data on the size of the LTWL (crosses) as in 
Chaib et al. [17] and the result of the application of equation (17) (dots). 
 
 
 1933
1945
1957
1969
1981
1993
2005
0
100
200
300
400
500
600
0
10
20
30
40
50
60
70
80
R
e
p
o
rt
e
d
 H
C
V
 i
n
fe
ct
io
n
s
Age (years)
 1933
1953
1973
1993
0.0E+00
1.0E+03
2.0E+03
3.0E+03
4.0E+03
5.0E+03
6.0E+03
7.0E+03
0
10
20
30
40
50
60
70
In
ci
d
e
n
ce
Age (years)
 0
2000
4000
6000
8000
10000
12000
14000
1998 2000 2002 2004 2006 2008 2010 2012 2014
N
u
m
b
e
r 
o
f 
P
a
ti
e
n
ts
 i
n
 t
h
e
 L
T
W
L
Year
 
